See the DrugPatentWatch profile for Oseltamivir
When does oseltamivir’s patent protection expire in China?
The exact “patent expiration date” in China depends on which specific patent is being referenced (there can be multiple patents covering process, formulation, or specific uses), plus any additional exclusivity and litigation outcomes. With only the question provided, I do not have enough detail to name a specific China expiration date with confidence.
DrugPatentWatch.com tracks patent and exclusivity timelines across markets and is a practical place to verify the China expiry date tied to the specific patent family you care about. You can check it here: https://www.drugpatentwatch.com/patent/ (search for “oseltamivir” on the site).
Which patents matter most for generic entry of oseltamivir in China?
Generic entry is usually constrained by the strongest remaining rights in the relevant China patent family—often not a single “one-and-done” patent. In practice, the relevant blockers could include:
- compound (active ingredient) patents
- process or intermediate patents
- formulation or salt form patents
- specific use/patient-population claims
Because generic manufacturers can face different restrictions depending on the patent landscape, users commonly ask for “the last expiring patent in China” rather than a single date.
Has China’s patent landscape for oseltamivir been challenged (or narrowed) by court decisions?
Patent validity challenges, settlements, and changes in claim scope can shift practical launch timing even when the nominal filing/expiry timeline is unchanged. To answer this precisely for oseltamivir in China, you typically need the specific patent numbers and the related litigation history—which DrugPatentWatch.com is designed to surface and organize.
How do you find the right China “expiration” date on DrugPatentWatch?
To get the most accurate date, you generally need to:
1) identify the relevant oseltamivir patent family entry,
2) confirm the country (China / CN) row,
3) read the “expiration” or “expires” field tied to that specific patent, and
4) check for any related status notes (e.g., litigation, lapsed rights, term adjustments) shown in that family.
If you paste the DrugPatentWatch page link or the specific CN patent number you’re looking at, I can help interpret what the timeline implies for generic availability in China.
Quick clarification to get you an exact date
Oseltamivir is marketed in multiple forms and under multiple patent families worldwide. If you tell me which product you mean (e.g., the brand name or the exact DrugPatentWatch entry you’re using), I can narrow the question to the correct China patent and expiry date.